Monitoring babies hospitalized with bronchiolitis
Part of Infections, Lungs & breathing clinical trials.
This study follows babies under 12 months old who are hospitalized with bronchiolitis to understand their treatment and outcomes. It includes tracking RSV testing and a new immunization called nirsevimab, which may help protect against severe illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is under 12 months old.
- Your baby is being treated at one of the 12 participating hospitals.
- Your baby is hospitalized for bronchiolitis (a lung infection).
- Your baby will have an RSV test (a test for a common respiratory virus).
- Your baby's immunization status for nirsevimab (a preventive shot against RSV) for the 2025/2026 season must be known.
- You agree to participate (legal guardian's consent).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the germs in a baby's gut and their immune system respond to bronchiolitis (a common lung infection). If your baby is under 12 months and gets bronchiolitis during the RSV season, their participation could help us understand why some babies get very sick and others don't.
This study looks at how the bacteria in the gut and the immune system respond in infants hospitalized with severe RSV infection. It may help doctors understand why some babies get sicker and could lead to better treatments.
This trial looks at how doctors treat babies hospitalized with bronchiolitis. It aims to understand which treatments are really needed and where care could be improved. If your baby was recently admitted for bronchiolitis, this study might help future babies get better, simpler care.
This trial tests a medication called peginterferon to treat RSV bronchiolitis (a lung infection causing wheezing and breathing trouble) in children ages 6 months to 2 years. It aims to see if the drug helps them recover faster.
This study looks at how well the new nirsevimab vaccine works against bronchiolitis in babies. If your infant has their first bout of bronchiolitis and gets a nose swab, they may be able to help researchers understand how the virus spreads and how to better protect other babies.
This trial looks at how well the drug nirsevimab works for babies hospitalized with RSV bronchiolitis. It also studies the body's immune response and the baby's environment. The goal is to see if nirsevimab can help infants recover from this serious lung infection.
Hear when a new Bronchiolitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.